Merz Aesthetics, an independent international aesthetics and neurotoxin company, which is part of the global Merz Pharma Group, has announced that the company is introducing Ultherapy treatment to India. Ultherapy is the only non-invasive treatment cleared by the US Food and Drug Administration (FDA) for lifting the skin on the neck, chin, and brow, and improving lines and wrinkles on the décolletage. Ultherapy is one of many innovations from Merz Aesthetics' in the field of aesthetic medicine since creating the world’s first anti-wrinkle cream in 1953. “Till date more than 1.5 million treatments have been accomplished globally with Ultherapy,” said Merz regional commercial director, Raymond Ong. “We’re very happy to see how it has been received, and are inspired to continue providing patients with more ways to have access to Ultherapy as Merz enjoys 111th year of existence in the industry. Also, as the world of aesthetic treatment is now moving towards a combination treatment approach, we are happy to remain the only company in the world to offer a combination of toxin, dermal fillers and energy-based devices for skin lifting & tightening to the patients,” he asserts.